Trials / Unknown
UnknownNCT03064282
Prostatic Hyperplasia Treatment and Cancer Prevention
Treatment of Prostatic Hyperplasia With Topical Papaverine
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Manchanda Medical Clinic · Academic / Other
- Sex
- Male
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Treatment of patients with prostatic hyperplasia with topical papaverine.
Detailed description
Patients with obstructive voiding and high PSA to be studied for the regression of symptoms and declining PSA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Placebo | observation of skin changes if any |
| DRUG | papaverine | observation of symptoms |
Timeline
- Start date
- 2021-06-30
- Primary completion
- 2021-09-30
- Completion
- 2021-12-01
- First posted
- 2017-02-27
- Last updated
- 2021-02-25
Source: ClinicalTrials.gov record NCT03064282. Inclusion in this directory is not an endorsement.